Results 101 to 110 of about 22,663 (193)

Repurposing FDA‐Approved Drugs to Inhibit Fungal PPTases for Broad‐Spectrum Synergy

open access: yesAdvanced Science, Volume 13, Issue 63, 12 November 2026.
Fungal secondary metabolites serve as crucial virulence effectors; however, the potential of their biosynthetic pathways as antifungal targets remains inadequately comprehended. Repurposed FDA‐approved drugs inhibit fungal PPTase (essential for secondary metabolism) in vivo.
Zili Song   +7 more
wiley   +1 more source

Xylosyltransferases in Cryptococcus laurentii

open access: yesJournal of Biological Chemistry, 1972
Abstract A particle-bound enzyme preparation from the fungus imperfectus, Cryptococcus laurentii, contains at least two different xylosyltransferases. One of these catalyzes the transfer of xylosyl units from UDP-xylose to endogenous cell envelope glycoproteins.
J S, Schutzbach, H, Ankel
openaire   +2 more sources

An acidic microenvironment increases NK cell killing of Cryptococcus neoformans and Cryptococcus gattii by enhancing perforin degranulation. [PDF]

open access: yes, 2013
Cryptococcus gattii and Cryptococcus neoformans are encapsulated yeasts that can produce a solid tumor-like mass or cryptococcoma. Analogous to malignant tumors, the microenvironment deep within a cryptococcoma is acidic, which presents unique challenges
Paul Oykhman   +8 more
core   +1 more source

First report of environmental isolation of Cryptococcus and Cryptococcus-like yeasts from Boyacá, Colombia

open access: yes, 2023
The Cryptococcus genus comprises more than 100 species, of which C. neoformans and C. gattii are the leading cause of cryptococcosis. The distribution of C. gattii and C.
Maribel Forero-Castro   +5 more
core   +1 more source

Biosynthetic Pathways and Regulation of Antibacterial Compounds From Endophytic Fungi: From Chemistry to Genomics and Biotechnology

open access: yesChemistry &Biodiversity, Volume 23, Issue 11, November 2026.
Endophytic fungi encode abundant cryptic biosynthetic gene clusters that remain largely silent under conventional cultivation. This review highlights how genome mining, multi‐omics, and cluster activation strategies bridge the BGC‐to‐metabolite gap, enabling the discovery of structurally diverse antibacterial natural products with activity against ...
Farkhod Eshboev   +8 more
wiley   +1 more source

Innate Immune Responses to Cryptococcus

open access: yes, 2017
Cryptococcus species are encapsulated fungi found in the environment that predominantly cause disease in immunocompromised hosts after inhalation into the lungs.
Lena J. Heung, Lena Heung
core   +1 more source

Literature-Based Gene Curation and Proposed Genetic Nomenclature for Cryptococcus [PDF]

open access: yes, 2014
Cryptococcus, a major cause of disseminated infections in immunocompromised patients, kills over 600,000 people per year worldwide. Genes involved in the virulence of the meningitis-causing fungus are being characterized at an increasing rate, and to ...
Inglis, Diane O   +5 more
core   +1 more source

Meroterpenoids Produced by Fungi: Occurrence, Structural Diversity, and Biological Activity (An Update: February 2020 to December 2025)

open access: yesChemistry &Biodiversity, Volume 23, Issue 11, November 2026.
This review firstly summarizes the update of meroterpenoids from February 2020 to December 2025 by applying a new classification method based on twelve key non‐terpene precursors. ABSTRACT Meroterpenoids are a class of hybrid natural products, biosynthesized from terpenoid fragments and non‐terpenoid precursors, exhibiting a wide range of biological ...
Yuqian Tang   +6 more
wiley   +1 more source

Biology of Cryptococcus gattii [PDF]

open access: yes
Cryptococcus gattii lives in the environment (1), usually in association with certain trees or soil around trees. Humans and animals can become infected with C.

core  

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6320-6369, November 2026.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy